Passionate about making a difference for patients.
San Francisco, CA
Joined March 2011
- Tweets1.2K
- Following655
- Followers693
- Likes2.3K
Marianne De Backer, MSc, PhD, MBA retweeted
Congrats to Foundation Board Member Marianne De Backer (@MDDBacker) on her new appointment!
bit.ly/40jzG7w
Marianne De Backer, MSc, PhD, MBA retweeted
Legendary biotech leader George Scangos, PhD, today announced his retirement after a storied career delivering impactful medicines to patients worldwide. With his support, Vir's BOD unanimously appointed Marianne De Backer, MSc, PhD, MBA, as his successor. bit.ly/3J94z8u
Adding Blackford and its AI technology to our radiology portfolio secures Bayer an excellent position in the fastest growing segment within the overall global radiology industry businesswire.com/news/home/2…
Marianne De Backer, MSc, PhD, MBA retweeted
Mit dieser Haushaltsentscheidung entsteht ein gutes Stück mehr Zukunft für den Standort Deutschland und Hoffnung für viele Patienten überall auf unser Welt.
Der Haushaltsausschuss des Bundestages hat eine Startfinanzierung für das geplante Translationszentrum Gen- und Zelltherapien von @Bayer und @ChariteBerlin auf den Weg gebracht. Ein wichtiges Signal für die #BrainCityBerlin!
ALT Zitat mit Foto der Regierenden Bürgermeisterin: „Das Translationszentrum für Gen- und Zelltherapien ist ein echter Gewinn für Berlin, den Forschungsstandort Deutschland und für Patientinnen und Patienten weltweit, die von den dort entwickelten Therapieansätzen profitieren werden.“
Marianne De Backer, MSc, PhD, MBA retweeted
🆕 @NatureMedicine
Heart manifestations of #LongCovid
A prospective MRI study of 346 people with mild Covid, and controls, demonstrated myocardial inflammation at 3 months, worse w/ symptoms, and edema at ~1 year
by @v_puntmann and colleagues @GoetheCVI
nature.com/articles/s41591-0…
Marianne De Backer, MSc, PhD, MBA retweeted
Proud to announce our newest investment in @ReCodeTx, a company pioneering game-changing #precisionmedicine for underserved patients with #geneticdiseases, like #cysticfibrosis. Learn about their technology: bwnews.pr/3OFKUwq
Join @McKinsey’s session live now about funding transformational platforms to learn more about @BayerPharma’s external innovation strategy: bio.org/events/bio-internati…
#bio2022 #limitlesstogether #collaboratetocure #teambayer
Getting ready to discuss how to cultivate #innovation post-acquisition via our arm’s length model with Jeff Hatfield from @VividionRx.
#BIO2022 #collaboratetocure #teambayer #limitlesstogether
Congratulations to @Evotec and the @BayerPharma BD&L/OI team, especially Christoph Huwe, for winning the @ASAP_Global Alliance Excellence award! This recognition is a testament to our #collobaratetocure approach to partnerships.
Marianne De Backer, MSc, PhD, MBA retweeted
We entered into a license agreement with a new joint venture, Visirna Therapeutics, Inc. #Visirna will develop and commercialize four of Arrowhead’s investigational #RNAi therapeutics for #cardiometabolic diseases in Greater China. Learn more here: bit.ly/3KcU5le $ARWR
Marianne De Backer, MSc, PhD, MBA retweeted
The VISTA program is a series of mid to late-stage clinical trials for those with #CardiovascularDiseases. With investigational #RNAi candidate ARO-ANG3, we hope to provide a potential treatment. Learn more about our three ongoing VISTA studies here: bit.ly/3oCGJ7u $ARWR
Marianne De Backer, MSc, PhD, MBA retweeted
Our new commercial manufacturing facility opened last year added 300,000 square feet of capacity, with each of the 9 suites offering up to 2,000L scales. It also houses in-house fill and finish QC labs and warehousing that makes #Viralgen the largest #AAV CDMO worldwide. 🧪🔬
Marianne De Backer, MSc, PhD, MBA retweeted
Happening now at @MilkenInstitute Conference: “How Can We Ensure Access to Innovation for All?” W/@drmeenasesh @MDDBacker @JayasreeKIyer and AmirAli Talasaz of @GuardantHealth. Hosted by Mark McClellan of @DukeMargolis.
I'm honored to join the @MilkenInstitute's 25th #MIGlobal Conference to discuss "How Can We Ensure Access to Health Innovation for All" with leaders from health organizations that are focused on patient access.
Join us: milkeninstitute.org/video/he…
#teambayer #healthinnovation
ALT Milken Institute panel on health innovation access
Marianne De Backer, MSc, PhD, MBA retweeted
Since joining @Bayer in 2019, industry veteran Marianne De Backer spearheaded the signing of nearly 30 new alliances and made four acquisitions. Recently, @MDDBacker launched a program to promote career development of underrepresented groups. #WILS2021 fiercepharma.com/special-rep…
Marianne De Backer, MSc, PhD, MBA retweeted
And the 2021 Entrepreneur Of The Year® National Overall Award Winner is...Sheila Mikhail of @ask_bio! Congratulations to this incredible entrepreneur who is making a tangible impact in the healthcare of our current and future generations. spr.ly/6019JdSy1 #EOYUS
ALT EOYUS 2021 National Overall Award Winner, Sheila Mikhail of AskBio
So happy to join the #GCVSymposium and James Mawson live in London for a fireside chat on the past, current and future developments in healthcare and @BayerPharmaceuticals unique approach to #investing and #partnering. #collaboratetocure @GCVenturing
ALT Fireside chat with Dr. De Backer and James Mawson on the new era of partnering and investing at the Global Corporate Venturing Symposium
Marianne De Backer, MSc, PhD, MBA retweeted
Using Viralgen's optimized platform for AAV manufacturing allows for data-driven decisions at every stage of development, from 2L to 2000L. 📈🔍 #OptimizedManufacturingPlatform
🔗 Learn more about our capabilities at viralgenvc.com/services.